Reversal of Hypolipidemia in Chronic Hepatitis C Patients After Successful Antiviral Therapy

Reversal of Hypolipidemia in Chronic Hepatitis C Patients After Successful Antiviral Therapy

Chronic infection with the hepatitis C virus (HCV) is associated with impaired lipid metabolism. The aim of this study was to determine the impact of antiviral response on the serial change of serum lipids in chronic HCV patients. Methods: A total of 165 consecutive patients with HCV infection were...

Full description

Bibliographic Details
Main Authors:	Yuan-Hung Kuo, Tang-Wei Chuang, Chao-Hung Hung, Chien-Hung Chen, Jing-Houng Wang, Tsung-Hui Hu, Sheng-Nan Lu, Chuan-Mo Lee
Format:	Article
Language:	English
Published:	Elsevier 2011-06-01
Series:	Journal of the Formosan Medical Association
Subjects:	cholesterol (TC) hepatitis C virus peginterferon reversal triglyceride
Online Access:	http://www.sciencedirect.com/science/article/pii/S0929664611600545

Similar Items

Successful Antiviral and Antituberculosis Treatment With Pegylated Interferon-alfa and Ribavirin in a Chronic Hepatitis C Patient With Pulmonary Tuberculosis
by: Ming-Chao Tsai, et al.
Published: (2009-09-01)

Hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial
by: Mazhar Haque, et al.
Published: (2009-01-01)

Peginterferon Treatment In Children: A Review Of Chronic Hepatitis B And Chronic Hepatitis C Treatment
by: Makbule EREN
Published: (2009-11-01)

Hepatitis C virus infection in patients with hemophilia in Korea: Is antiviral therapy effective and safe?
by: Woo Sun Rou, et al.
Published: (2015-06-01)

Is peginterferon and ribavirin therapy effective in Korean patients with chronic hepatitis C?
by: Young Kul Jung, et al.
Published: (2013-03-01)

Chronic hepatitis C: hepatic iron content does not correlate with response to antiviral therapy Hepatite C crônica: concentração hepática de ferro não é correlacionada com a resposta ao tratamento antiviral
by: Patricia da Silva Fucuta Pereira, et al.
Published: (2009-12-01)

Cost-Effectiveness and Clinical Impact of Antiviral Strategies of HBeAg-Positive and -Negative Chronic Hepatitis B
by: Itziar Oyagüez, et al.
Published: (2017-05-01)

Influence of some methylated hepatocarcinogenesis-related genes on the response to antiviral therapy and development of fibrosis in chronic hepatitis C patients
by: Waleed Seif Eldin Mohamed Mostafa, et al.
Published: (2020-01-01)

A practical guide for antiviral therapy of chronic Hepatitis C
by: José Velosa, et al.
Published: (2014-11-01)

Outcome of combination antiviral therapy in chronic hepatitis C virus infection during therapy of acute lymphoblastic leukemia
by: Muhammad Ayyub, et al.
Published: (2011-01-01)

Depression and anxiety disorders during pegylated interferon treatment in patients with chronic hepatitis B
by: Ozen Onen Sertoz, et al.
Published: (2017-01-01)

Pharmacoeconomics applied to chronic hepatitis C
by: Fernando Franciosi Tatsch, et al.

Highly effective peginterferon α-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea
by: Suh Yoon Yang, et al.
Published: (2015-06-01)

Hepatitis B virus surface antigen seroconversion in HIV-infected individual after pegylated interferon-alpha treatment: a case report
by: Adriane Maira Delicio, et al.
Published: (2013-12-01)

The effectiveness of retreatment with peginterferon alfa and ribavirin in patients with chronic viral hepatitis C genotype 2 and 3: a prospective cohort study in Brazil
by: Artico Simara, et al.
Published: (2012-12-01)

Side effects of medical therapy for chronic hepatitis C
by: Shiffman Mitchell L, MD
Published: (2004-01-01)

Peginterferon alpha-based therapy for chronic hepatitis B focusing on HBsAg clearance or seroconversion: a meta-analysis of controlled clinical trials
by: Zhang Yu-guo, et al.
Published: (2011-06-01)

Hepatic fibrosis in patients with chronic hepatitis C assessed by transient elastography: implications for determining the efficacy of antiviral therapy Evaluación de la fibrosis hepática en pacientes con hepatopatía crónica C mediante elastografía transitoria: implicaciones para determinar la eficacia del tratamiento antiviral
by: J. Mendoza, et al.
Published: (2010-07-01)

Treatment with pegylated interferon alpha 2b and ribavirin in patients unresponsive to previous treatments with standard interferon as monotherapy or combined with ribavirin Tratamiento con PEG interferón alfa 2b y ribavirina en enfermos previamente tratados con interferón estándar en monoterapia o combinado con ribavirina
by: F. Carnicer, et al.
Published: (2005-05-01)

Efficacy of Pegylated Interferon Monotherapy versus Sequential Therapy of Entecavir and Pegylated Interferon in Hepatitis B e Antigen-Positive Hepatitis B Patients: A Randomized, Multicenter, Phase IIIb Open-Label Study (POTENT Study)
by: Dae Won Jun, et al.
Published: (2018-01-01)

Long-term effects of treatment and response in patients with chronic hepatitis C on quality of life. An international, multicenter, randomized, controlled study
by: Bezemer Geert, et al.
Published: (2012-01-01)

Treatment of HCV infection in patients with cirrhosis
by: Angelo Alves de Mattos, et al.
Published: (2010-01-01)

The Sustained Virologic Response and Adverse Effects of Peg Interferon Alfa and Ribavirin in the Treatment of Patients with Chronic Hepatitis C: A Study from Iran
by: Simindokht Shoaei, et al.
Published: (2017-10-01)

HBsAg loss with HBsAg/anti-HBs seroconversion and non-detectable HCV-RNA in a patient with chronic HBV e-minus/HCV hepatitis treated with two cycles of antiviral therapy
by: Antonio Salvio, et al.
Published: (2012-01-01)

Peginterferon alfa-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in retreatment of chronic hepatitis C patients, nonresponders and relapsers to previous conventional interferon plus ribavirin therapy
by: E. Parise, et al.

Clinical characteristics of chronic hepatitis B cured by peginterferon in combination with nucleotide analogs
by: Xuli Bao, et al.
Published: (2020-07-01)

Evaluation of Dual Therapy in Real Life Setting in Treatment-Naïve Turkish Patients with HCV Infection: A Multicenter, Retrospective Study
by: Yunus Gürbüz, et al.
Published: (2016-02-01)

Antimitochondrial antibody serocoversion post-liver transplant during hepatitis C treatment with peginterferon α, ribavirin and telaprevir
by: Vladimir Marquez-Azalgara, et al.
Published: (2014-09-01)

Comprehensive evaluation of apolipoprotein H gene (APOH) variation identifies novel associations with measures of lipid metabolism in GENOA*s⃞
by: Magalie S. Leduc, et al.
Published: (2008-12-01)

High effectiveness of peginterferon alfa-2a plus ribavirin therapy in Korean patients with chronic hepatitis C in clinical practice
by: Nae-Yun Heo, et al.
Published: (2013-03-01)

Repeated Panniculitis Induced by Pegylated Interferon Alpha 2a in a Patient with Chronic Hepatitis C
by: June Seok Song, et al.
Published: (2016-05-01)

Efficacy of peginterferon and ribavirin is associated with the IL28B gene in Korean patients with chronic hepatitis C
by: Seok Hoo Jeong, et al.
Published: (2012-12-01)

Thyroid dysfunction in Turkish patients with chronic hepatitis C receiving peginterferon plus ribavirin in the period of 2005-2010
by: Sener Barut, et al.

The Effects of Diosgenin on Hypolipidemia and Its Underlying Mechanism: A Review
by: Sun F, et al.
Published: (2021-09-01)

Sexual dysfunction in males with hepatitis C virus: Relevance to histopathologic changes and peginterferon treatment
by: Kamal A El-Atrebi, et al.
Published: (2011-01-01)

Evolution of antiviral treatment chronic for hepatitis B, C and D
by: K. V. Zhdanov, et al.
Published: (2014-09-01)

Sustained Virological Response after 8-Week Treatment of Simeprevir with Peginterferon α-2a plus Ribavirin in a Japanese Female with Hepatitis C Virus Genotype 1b and IL28B Minor Genotype
by: Tatsuo Kanda, et al.
Published: (2015-07-01)

Combination of Entecavir or Tenofovir with Pegylated Interferon-α for Long-Term Reduction in Hepatitis B Surface Antigen Levels: Simultaneous, Sequential, or Add-on Combination Therapy
by: Kanako Yoshida, et al.
Published: (2021-02-01)

Efficacy and safety of pegylated-interferon alpha therapy in patients with chronic hepatitis B in recource-limited settings- Serbian single-center experience
by: Bojović Ksenija, et al.
Published: (2020-01-01)

Antinuclear antibody titer and treatment response to peginterferon plus ribavirin for chronic hepatitis C patients
by: Ming-Yen Hsieh, et al.
Published: (2012-02-01)

Cannot write session to /tmp/vufind_sessions/sess_fovq4hbn0v99q3kboht5mtrl09